Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Neuro-Oncology|February 3, 2026
Meningioma microenvironment harbors a rich immune landscape that evolves with biological stateXiaopeng Guo, Zachary A Moynihan, Joseph Driver, et al.Biorxiv : the Preprint Server for Biology|July 28, 2023
NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapyAbrar Choudhury, Martha A Cady, Calixto-Hope G Lucas, et al.Nature|May 3, 2023
Glioblastoma remodelling of human neural circuits decreases survivalSaritha Krishna, Abrar Choudhury, Michael B Keough, et al.Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.Cancer Research|July 25, 2025
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiation TherapyCory M Richman, Alexandra Rasnitsyn, Borja L Holgado, et al.International Journal of Radiation Oncology, Biology, Physics|April 9, 2026
Improved progression-free survival following dose-escalated vs. standard dose post-operative radiation therapy for high-risk meningiomas: An International Multicenter Individual Patient Level Meta-Analysis (FIRESTORM)Raj Singh, Andrew Koempel, Beck French, et al.Journal of Neuropathology and Experimental Neurology|June 15, 2022
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-GangliogliomaCalixto-Hope G Lucas, Christian J Davidson, Mouied Alashari, et al.Neuro-Oncology|September 11, 2021
A molecularly integrated grade for meningiomaJoseph Driver, Samantha E Hoffman, Sherwin Tavakol, et al.Brain Pathology (Zurich, Switzerland)|March 25, 2024
NAB2::STAT6 fusions and genome-wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumorsKathryn L Eschbacher, Quynh T Tran, Evgeny A Moskalev, et al.Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.Pageof 17